Canada markets closed

Evome Medical Technologies Inc. (LNDZF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.21000.0000 (0.00%)
At close: 01:45PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 14.27M
Enterprise Value 31.47M
Trailing P/E 20.45
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.34
Price/Book (mrq)5.72
Enterprise Value/Revenue 0.50
Enterprise Value/EBITDA -3.75

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-23.64%
S&P500 52-Week Change 321.23%
52 Week High 30.3150
52 Week Low 30.0210
50-Day Moving Average 30.1753
200-Day Moving Average 30.1696

Share Statistics

Avg Vol (3 month) 3934
Avg Vol (10 day) 3N/A
Shares Outstanding 557.83M
Implied Shares Outstanding 692.92M
Float 849.23M
% Held by Insiders 118.22%
% Held by Institutions 110.28%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 14, 2020
Ex-Dividend Date 4May 24, 2017
Last Split Factor 20.737:1
Last Split Date 3Dec 15, 2020

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -26.01%
Operating Margin (ttm)-17.90%

Management Effectiveness

Return on Assets (ttm)-31.11%
Return on Equity (ttm)-161.40%

Income Statement

Revenue (ttm)59.99M
Revenue Per Share (ttm)0.82
Quarterly Revenue Growth (yoy)36.50%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-15.6M
Diluted EPS (ttm)-0.1500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)918.68k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)24.69M
Total Debt/Equity (mrq)616.76%
Current Ratio (mrq)0.56
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-918.91k
Levered Free Cash Flow (ttm)N/A